6,678 trials
Small for Gestational Age
Primary: Number of Participants With Development of Diabetes in Short Children Born SGA During Treatment — 0 Participants
Diabetes Mellitus, Type 2
Primary: Change in HbA1c From Baseline After 52 Weeks of Treatment — -0.12; -0.69 percentage of glycated hemoglobin — p=<0.0001
Hemophilia A
Primary: Number of Participants With Serious Adverse Events (SAE) at Least Possibly Related to ADVATE — 0 Participants
Quadratus Lumborum Block · Surgical Wound Infiltration
Primary: Opioid Consumption in Oral Morphine Milliequivalents for the First 24 Hours After Surgery (Defined as 24 Hours After the Anesthesia End Time) — 17.50; 21.25 oral…
HIV-1-infection
Primary: Viral Suppression — 100 percentage of participants
Spray · Pain · Safety Issues
Primary: Presence of Microbial Growth (1+ CFU) — 2; 1; 1; 1 Number of samples with 1+ CFU — p=0.317
Effect of Drug
Primary: Effect of Trypsin-Chymotrypsin on Post-operative Pain After Single Endodontic Treatment in Teeth With Symptomatic Irreversible Pulpitis — 3.47; 3.53; 2.93; 6.13 score on…
Type 1 Diabetes
Primary: Mean Change in Percent Time in Range — 2; -6.1 percentage of time in measured period — p=0.14
Musculoskeletal Pain
Primary: Change in Pain Assessment — 2.9; 4.0 score on a scale
Endoscopic Ultrasound (EUS) · Endoscopic Retrograde Cholangiopancreatography (ERCP)
Primary: Average Percentage of Sedation Failures — 14; 13; 5 percentage of participants
Bleeding Complications
Primary: Ischemic Risk Post-PCI in High Bleed Risk Patients With Genotype-guided Single Antiplatelet Therapy — 0; 1 Participants
Pleural Diseases
Primary: Number of Hospital Days for Required to Treat Complicated Parapneumonic Effusions or Pleural Empyema. — 13; 18.5 days
Glabellar Frown Lines
Primary: Time Needed to Prepare Alluzience and Powder BoNT A — 0.55; 1.57 Minutes
Type 2 Diabetes Mellitus
Primary: Number or Participants With Hypoglycemic Events — 10 participants
Post-operative Nausea and Vomiting · Laparoscopic Sleeve Gastrectomy
Primary: Number of Participants With PONV-related Delay of Hospital Discharge — 0; 4 Participants